Novartis hosts management event to outline growth outlook
NVS•Novartis’s November 19 event in London featured CEO Vas Narasimhan’s strategy update, with projected net sales growth of 5% annually at constant currencies from 2026 to 2031 and core operating income margin expected to return above 40% by 2029.




